000 | 01169 a2200325 4500 | ||
---|---|---|---|
005 | 20250516194834.0 | ||
264 | 0 | _c20140926 | |
008 | 201409s 0 0 eng d | ||
022 | _a1750-1172 | ||
024 | 7 |
_a10.1186/1750-1172-9-20 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aUguen, David | |
245 | 0 | 0 |
_aAccelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectives. _h[electronic resource] |
260 |
_bOrphanet journal of rare diseases _cFeb 2014 |
||
300 |
_a20 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aEuropean Union |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aOrphan Drug Production |
650 | 0 | 4 | _aRare Diseases |
700 | 1 | _aLönngren, Thomas | |
700 | 1 | _aLe Cam, Yann | |
700 | 1 | _aGarner, Sarah | |
700 | 1 | _aVoisin, Emmanuelle | |
700 | 1 | _aIncerti, Carlo | |
700 | 1 | _aDunoyer, Marc | |
700 | 1 | _aSlaoui, Moncef | |
773 | 0 |
_tOrphanet journal of rare diseases _gvol. 9 _gp. 20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1750-1172-9-20 _zAvailable from publisher's website |
999 |
_c23531981 _d23531981 |